Avadel Pharmaceuticals PLC (AVDL) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

Avadel Pharmaceuticals PLC (AVDL) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $23.25 Million represents 1% of operating cash flow ($23.26 Million). See AVDL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$23.25 Million
USD

Operating Cash Flow

$23.26 Million
USD

Capital Expenditures

$10.76K
USD

Avadel Pharmaceuticals PLC Free Cash Flow Generation Index (2002–2017)

Historical FCF Generation Index trend for Avadel Pharmaceuticals PLC across 6 annual periods. Explore Avadel Pharmaceuticals PLC cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Avadel Pharmaceuticals PLC (2002–2017)

Year-by-year Free Cash Flow Generation Index for Avadel Pharmaceuticals PLC. For the full company profile including market capitalisation, see market value of Avadel Pharmaceuticals PLC.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2017 -2.22x $-37.04 Million $16.66 Million $53.70 Million ▼ -337.4%
2016 0.94x $17.70 Million $18.90 Million $1.20 Million ▼ -4.5%
2015 0.98x $82.66 Million $84.29 Million $1.63 Million ▲ +25.1%
2009 0.78x $6.42 Million $8.20 Million $1.77 Million ▲ +2.1%
2003 0.77x $9.39 Million $12.23 Million $2.84 Million ▼ -8.2%
2002 0.84x $7.34 Million $8.77 Million $1.44 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).